Monoamines and their metabolites in plasma and lumbar cerebrospinal fluid of Chinese patients with Parkinson's disease
- 1 June 1993
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 116 (2) , 125-134
- https://doi.org/10.1016/0022-510x(93)90316-q
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Treatment of idiopathic parkinsonism with l-dopa in the absence and presence of decarboxylase inhibitors: effects on plasma levels of l-dopa, dopa decarboxylase, catecholamines and 3-O-methyl-dopaZeitschrift für Neurologie, 1989
- Cerebrospinal fluid homovanillic acid and parkinsonism in Huntington's diseaseAnnals of Neurology, 1988
- A new approach to biochemical evaluation of brain dopamine metabolismCellular and Molecular Neurobiology, 1988
- CSF Monoamine Metabolite Levels in Alzheimer's and Parkinson's DiseaseArchives of Neurology, 1985
- CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.Journal of Neurology, Neurosurgery & Psychiatry, 1977
- “Mini-mental state”Journal of Psychiatric Research, 1975
- L-Dopa induced changes in central monoamine neurons after peripheral decarboxylase inhibitionJournal of Pharmacy and Pharmacology, 1970
- HOMOVANILLIC ACID AND 5‐HYDROXYINDOLEACETIC ACID IN THE CEREBROSPINAL FLUID OF PATIENTS WITH SENILE DEMENTIA, PRESENILE DEMENTIA AND PARKINSONISMJournal of Neurochemistry, 1969
- The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly SubjectsThe British Journal of Psychiatry, 1968
- ParkinsonismNeurology, 1967